Other key highlights from the report include:
Maternal Health and Newborn Mortality
Validating a simplified approach to manage the third stage of labor that will enable lower-level skilled birth attendants to also manage inadequate contractions of the uterus, a cause of hemorrhage and death.
Demonstrating through evaluative research the efficacy of training lower-level health professionals to manage asphyxia, a leading cause of newborn mortality.
Developing and introducing chlorhexidine (CHX) antiseptic for umbilical cord care – a new, low-cost preventive intervention to reduce newborn infection, which causes up to 24 percent of newborn mortality.
Saving Lives at Birth
Stimulating new approaches to support innovation. In partnership with Canada, the United Kingdom, Norway and the Bill & Melinda Gates Foundation, Saving Lives at Birth: A Grand Challenge for Development promotes disruptive technology development and helps drive innovative solutions.
Expanding contraceptive options through the development of a multipurpose diaphragm. The SILCS diaphragm is a cervical barrier method that does not require a pelvic exam, is reusable and can potentially protect against HIV and sexually transmitted infections when paired with microbicide gels.
HIV Vaccine Research
Accelerating progress on HIV vaccine research by analyzing antibodies that neutralize a broad spectrum of HIV.
Preventing Pandemic Threats
Developing the first-ever scientifically based prediction tool of unknown viruses that are potential candidate sources for emerging pandemic threats.
Detecting Counterfeit and Substandard Medicine
Advancing from proof-of-concept, a prototype of a portable device for detecting counterfeit and substandard medicines. This device is less expensive and more accurate than current technologies.
Read the full report here.